|
|
15010 Broschart Road Rockville, MD 20850-6365 USA phone:301-251-4443 fax:301-251-4446
|
|
| Symbol |
Private |
| Founded |
2006 |
| Employees |
13 |
|
|
| www.theranosticshealth.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Technology is the merger of therapeutics and diagnostics |
 |
| Management |
| Glenn D. Hoke, Ph.D., President and CEO; Ronald S. Hencin, Ph.D., VP of Business Development; John G. Hartwell, Senior Director of Sales and Marketing; Corinne Ramos, Ph. D., Director of Clinical Research |
| |
|
|
| |
|
| Keywords |
| Laser Capture Microdissection, Reverse-phase Protein Microarrays, Biomarker Discovery, Proteomics, Signal Transduction Pathway Analysis |
|
|
|
| Description |
|
Theranostics Health is a proteomics-based diagnostics company that provides research services to drug development companies, and is developing diagnostic tests to enable personalized cancer therapies tailored to each patient’s tumor. Our technologies utilize Laser Capture Microdissection (LCM) and Reverse-phase Protein MicroArrays (RPMA) assays to accurately measure drug targets and their signaling pathways within tumor cells. Our technologies are of particular use for companies developing Molecular Targeted Therapies and allow insights into the phospho-activation status of drug targets, their downstream pathways and potential survival mechanisms or pathways within targeted cell populations and are utilized in a translational research manner from preclinical SAR-type studies through to Phase II clinical trials. |
 |
 |
|
|
|
|
|
|